digital health companies glp-1 weight loss The Impact of Agonists on the MedTech Sector: Articulating a continued value proposition for devices GLP-1 Telehealth Is Changing Fast

10.1016/j.preteyeres.2009.06.001

However, this structure also requires careful design to ensure the benefit remains a lifestyle reimbursement program rather than a regulated health plan

Secondary to the feeling of gastric fullness after receiving the drug, patients tend to reduce water intake, which may predispose them to this AE

Its unique mechanism of action provides additional metabolic benefits, such as improved glucose control and appetite suppression, making it appealing for both weight loss and diabetes management

Patients are encouraged to speak with their healthcare providers and insurance companies to understand their options and explore potential cost-saving measures

Semaglutide (Wegovy) is available in a weekly injectable form for weight loss